Evaluation of N6 Sound Processor in Group of Freedom Users

Study of freedom sound processor users that upgrade to N6 sound processor CP900 series. To test speech understanding in each device and usability of upgrade.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sensory Hearing Loss Ear Diseases Hearing Disorders Hearing Loss Hearing Loss, Sensorineural Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects with sensorineural hearing loss
12 years of age and older
Currently using Freedom Sound Processor
Recipient of a Ci22M or CI24 series implant
Minimum of 3 months experience with Freedom Sound Processor
Prior documentation of sentence recognition in noise at a +10 SNR or better
Native English speaker
Willingness to participate and comply with requirements of protocol

Exclusion criteria

Unable to complete test metrics
Unrealistic expectations regarding possible benefits
Additional handicaps that would prevent or restrict participation in audiological evaluations
ABI cochlear implant recipient

Treatment and study plan

Primary outcomes

Evaluation of N6 Sound Processor in Group of Freedom Users

Time frame: 3 months of use

Speech recognition measures in quiet & noise via word and sentence rest and SSiQ questionnaire to compare freedom to upgrade with N6 relative to speech, spatial and quality dimensions and N6 questionnaire.

Sponsors and collaborators

Lead sponsor

Cochlear

Industry

Registry information

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Aug 5, 2016
Registry last updated: Aug 5, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed